Zhu, Y., Xing, P., Wang, S., Ma, D., Mu, Y., Li, X., . . . Li, J. (2018). Evaluation of calculating carboplatin dosage in carboplatin–pemetrexed therapy as the first‐line therapy for Chinese patients with advanced lung adenocarcinoma. Thorac Cancer.
Styl ChicagoZhu, Yixiang, Puyuan Xing, Shouzheng Wang, Di Ma, Yuxin Mu, Xue Li, Ziyi Xu, a Junling Li. "Evaluation of Calculating Carboplatin Dosage in Carboplatin–pemetrexed Therapy As the First‐line Therapy for Chinese Patients With Advanced Lung Adenocarcinoma." Thorac Cancer 2018.
Citace podle MLAZhu, Yixiang, et al. "Evaluation of Calculating Carboplatin Dosage in Carboplatin–pemetrexed Therapy As the First‐line Therapy for Chinese Patients With Advanced Lung Adenocarcinoma." Thorac Cancer 2018.